Serum Separation Gel Market Size & Growth Forecast 2027–2036, By Segments (Product, Source), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Serum Separation Gel Market size was worth USD 8.84 billion in 2026 and is expected to grow at a 6.3% CAGR between 2027 and 2036, surpassing USD 16.28 billion by 2036. The industry revenue for 2027 is calculated at USD 9.37 billion.
Get more details on this report
Request Free Sample ReportSerum Separation Gel Market Intelligence Snapshot
Regional Market Dynamics
- North America leads through mature clinical diagnostics infrastructure, high routine blood testing volumes, established laboratory workflows, and broad adoption of advanced blood collection systems across healthcare facilities.
- Asia Pacific is expected to grow at a 7.91% CAGR, driven by expanding diagnostic testing, greater healthcare access, rising laboratory capacity, and increasing emphasis on reliable high-throughput specimen processing.
Segment Momentum
- They lead due to streamlined workflow efficiency, combining collection and separation in one system, improving sample consistency and reducing handling steps, making them preferred in high-throughput diagnostic laboratory environments.
- Pharmaceutical companies are the fastest-growing source due to expanding R&D needs requiring controlled, reproducible sample preparation and consistent separation performance across drug development and clinical testing workflows.
Market Expansion Drivers
- Expanding blood bank infrastructure increasing demand for serum collection and diagnostic testing.
- Rising bloodstream infection prevalence accelerating infectious disease diagnostic test volumes.
- Growing laboratory automation investments improving adoption of advanced specimen processing consumables.
Leading Market Participants
- Leading companies in the serum separation gel market include Becton, Dickinson and Company (United States), Abbott Laboratories (United States), F. Hoffmann-La Roche Ltd (Switzerland), Siemens Healthineers AG (Germany), Danaher Corporation (United States), QIAGEN N.V. (Netherlands), Bio-Rad Laboratories, Inc. (United States), Agilent Technologies, Inc. (United States), Thermo Fisher Scientific Inc. (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 8.84 billion
- 2027 Estimated Market Size: USD 9.37 billion.
- Projected Market Size: USD 16.28 billion by 2036
- Growth Forecast: 6.3% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Serum Separation Gel With Integrated Tubes (Product) | Blood Banks (Source)
- Emerging Opportunity Segment: Serum Separation Gel With Integrated Tubes (Product) | Pharmaceutical Companies (Source)
Market Growth Drivers and Industry Trends
Expanding blood bank infrastructure increasing demand for serum collection and diagnostic testing
Expansion of blood bank infrastructure across healthcare systems will drive the serum separation gel market growth by increasing the volume and frequency of blood sample collection, processing, and diagnostic testing. As blood banks expand their collection capacity and strengthen specimen-handling workflows, laboratories require reliable consumables that can support efficient separation of serum from blood components while maintaining sample integrity. Serum separation gels help create a physical barrier between serum and cellular components during centrifugation, reducing the risk of contamination and supporting consistent specimen preparation. Greater availability of organized blood collection facilities also increases demand for standardized sample-processing practices across hospitals, diagnostic centers, and blood banks, encouraging wider use of serum separation tubes and related consumables.
Rising bloodstream infection prevalence accelerating infectious disease diagnostic test volumes
The growing incidence of bloodstream infections is increasing the need for timely laboratory diagnosis, and this trend will propel the serum separation gel market growth as healthcare providers process more patient specimens for infectious disease evaluation. Bloodstream infections often require laboratory testing to identify underlying infections and guide appropriate clinical management, creating sustained demand for dependable blood collection and serum preparation procedures. Serum separation gels facilitate efficient specimen handling by supporting the clear separation of serum from blood cells, which can improve laboratory workflow and reduce unnecessary sample manipulation. Rising attention to early detection, infection monitoring, and diagnostic testing in hospitals further contributes to higher utilization of serum-based laboratory consumables.
Growing laboratory automation investments improving adoption of advanced specimen processing consumables
Investment in laboratory automation is encouraging diagnostic facilities to adopt consumables that can integrate smoothly with standardized and high-throughput specimen workflows, supporting growth of the serum separation gel market. Automated laboratories increasingly prioritize consistent sample preparation, reduced manual intervention, and efficient movement of specimens across collection, centrifugation, and analysis stages. Separation gels can support these requirements by providing a standardized approach to serum isolation and helping laboratories maintain uniform specimen quality during automated processing. As diagnostic laboratories modernize their infrastructure and expand automated testing capabilities, demand for compatible specimen-processing consumables is strengthened by the need to improve operational efficiency and minimize variability in routine sample handling.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising demand for serum separation in diagnostics | 2.20% | Short term (≤ 2 yrs) | North America, Europe | Medium | Fast |
| Advancements in gel and tube technologies | 2.40% | Medium term (2–5 yrs) | North America, Asia Pacific | Low | Moderate |
| Expansion of clinical labs in emerging markets | 2.40% | Long term (5+ yrs) | Asia Pacific, Latin America | Low | Slow |
| Expanding blood bank infrastructure increasing demand for serum collection and diagnostic testing | 2.00% | Moderate | North America, Asia Pacific, Europe | High | Near Term |
| Rising bloodstream infection prevalence accelerating infectious disease diagnostic test volumes | 1.80% | High | North America, Europe | High | Near Term |
| Growing laboratory automation investments improving adoption of advanced specimen processing consumables | 1.30% | Moderate | Asia Pacific, Latin America | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the serum separation gel market, North America held the largest share in 2026, supported by advanced clinical laboratory infrastructure, high adoption of automated diagnostic workflows, and strong demand for reliable specimen-processing technologies. Serum separation gels are widely used to facilitate efficient blood sample handling and improve the consistency of laboratory testing, making them well suited to the region's sophisticated healthcare environment. Growing diagnostic testing volumes, expansion of outpatient laboratory services, and increasing emphasis on efficient sample preparation are supporting demand. Continued laboratory automation and quality-focused practices further reinforce the region's established position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region, driven by expanding healthcare infrastructure, increasing access to clinical diagnostics, and rising demand for efficient laboratory testing across developing healthcare systems. Improvements in hospital and diagnostic laboratory capabilities are encouraging the adoption of standardized specimen collection and separation technologies. Growing awareness of laboratory quality, increasing healthcare expenditure, and broader availability of automated diagnostic equipment are creating favorable conditions for serum separation gel adoption. The expansion of preventive healthcare and diagnostic screening is also strengthening demand for dependable sample-processing solutions.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Diagnostic Material QualityGermany emphasizes premium serum separation gel materials that support precise clinical diagnostics and laboratory efficiency. Suppliers are focusing on product consistency, regulatory compliance, and compatibility with automated blood collection systems.
France 🇫🇷
Clinical Testing ReliabilityFrance continues to adopt serum separation gel products that improve sample preservation across hospital and diagnostic laboratory networks. Market activity centers on dependable specimen quality and compatibility with evolving laboratory testing requirements.
Italy 🇮🇹
Hospital Laboratory EfficiencyItaly is strengthening serum separation gel utilization as healthcare laboratories optimize blood collection and diagnostic workflows. Suppliers are focusing on dependable separation performance and product quality to support routine clinical testing across healthcare facilities.
Japan 🇯🇵
Precision Sample ProcessingJapan advances serum separation gel adoption by prioritizing reliable specimen handling in high-throughput diagnostic laboratories. Healthcare providers seek gel formulations that preserve sample quality while supporting increasingly automated laboratory operations.
South Korea 🇰🇷
Laboratory Innovation SupportSouth Korea is expanding the use of serum separation gel products alongside investments in advanced clinical laboratory infrastructure. Manufacturers are introducing improved gel technologies that enhance sample separation efficiency and analytical reliability.
United States 🇺🇸
High-Volume Laboratory SupplyThe U.S. maintains strong demand for serum separation gel products as laboratories expand automated blood collection and diagnostic testing capacity. Manufacturers are developing formulations that improve specimen stability and compatibility with modern laboratory workflows.
Segment Leadership and Growth Trends
Serum Separation Gel Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Serum Separation Gel With Integrated Tubes (Largest & Fastest-Growing Segment)
Serum separation gel with integrated tubes represented the largest share of the serum separation gel market in 2026 while also emerging as the fastest-growing product segment. The integrated configuration streamlines specimen collection and serum separation by combining key components into a convenient format, reducing handling requirements and supporting efficient laboratory workflows. Its ability to improve sample processing consistency, simplify preparation, and minimize opportunities for handling-related errors makes it attractive across diagnostic and clinical testing environments.
Source Segment Analysis: Blood Banks (Largest Segment) vs Pharmaceutical Companies (Fastest-Growing Segment)
Blood banks accounted for the largest share of the serum separation gel market in 2026, reflecting their significant requirement for efficient blood sample processing and reliable separation procedures. Serum separation products support organized specimen handling and help facilitate downstream laboratory analysis, making them valuable within workflows involving large volumes of collected samples. The need for consistent sample quality and streamlined processing further strengthens the position of blood banks as an important source segment.
Pharmaceutical companies are expected to record the fastest growth as expanding research, development, and analytical activities increase the need for dependable serum sample preparation. Serum separation gels can support laboratory workflows associated with biomarker analysis, clinical research, and other pharmaceutical testing activities by simplifying specimen processing. The growing emphasis on efficient sample handling and reproducible laboratory procedures is expected to encourage wider adoption within pharmaceutical research environments.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Serum Separation Gel Without Integrated Tubes, Serum Separation Gel With Integrated Tubes | Serum Separation Gel With Integrated Tubes | Serum Separation Gel With Integrated Tubes |
| Source | Blood Banks, Hospitals, Pharmaceutical Companies, Others | Blood Banks | Pharmaceutical Companies |
Competitive Landscape and Market Positioning
Major players in the serum separation gel market:
1. Becton Dickinson and Company (United States)
2. Abbott Laboratories (United States)
3. F. Hoffmann-La Roche Ltd (Switzerland)
4. Siemens Healthineers AG (Germany)
5. Danaher Corporation (United States)
6. QIAGEN N.V. (Netherlands)
7. Bio-Rad Laboratories Inc. (United States)
8. Agilent Technologies Inc. (United States)
9. Thermo Fisher Scientific Inc. (United States)
The serum separation gel market is experiencing steady innovation in sample processing efficiency and laboratory accuracy. Improved gel formulations are enhancing stability and separation performance in diagnostic workflows. Continuous R&D efforts are driving material refinement for better compatibility. Collaborative development activities are further supporting product consistency, strengthening the serum separation gel market in clinical and research applications.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Becton Dickinson and Company (United States) | |||||||
| Abbott Laboratories (United States) | |||||||
| F. Hoffmann-La Roche Ltd (Switzerland) | |||||||
| Siemens Healthineers AG (Germany) | |||||||
| Danaher Corporation (United States) | |||||||
| QIAGEN N.V. (Netherlands) | |||||||
| Bio-Rad Laboratories Inc. (United States) | |||||||
| Agilent Technologies Inc. (United States) | |||||||
| Thermo Fisher Scientific Inc. (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Serum Separation Gel Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Clinical Application | Clinical Chemistry, Immunoassay and Serology, Molecular Diagnostics, Therapeutic Drug Monitoring |
| Distribution Channel | Direct Sales, Medical Distributors, Online Sales |
| Purchase Model | Direct Procurement, Distributor-Based Procurement, Group Purchasing Organization (GPO) Procurement |
Serum Separation Gel Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Clinical Laboratory Workflow Optimization |
|
| Diagnostic Laboratory Demand and Adoption Opportunities |
|
| Supplier and Raw Material Risk Management |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of serum separation gel?
What are the growth projections for the serum separation gel industry?
How are integrated serum separation gel tubes influencing efficiency in high-throughput diagnostic laboratories?
What role is automation playing in shifting purchasing behavior toward advanced serum separation gel consumables?
Why do Serum Separation Gel With Integrated Tubes dominate this market?
Why is demand rising for serum separation gels among pharmaceutical companies?
What makes North America the largest regional market for serum separation gel?
Why is Asia Pacific emerging as the fastest-growing serum separation gel market?
Which companies dominate the serum separation gel landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization